Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Preferred Stock Liabilities (2020 - 2021)

Immuneering (IMRX) has 2 years of Preferred Stock Liabilities data on record, last reported at $21.1 million in Q2 2021.

  • For Q2 2021, Preferred Stock Liabilities changed 0.0% year-over-year to $21.1 million; the TTM value through Jun 2021 reached $21.1 million, changed 0.0%, while the annual FY2020 figure was $21.1 million, N/A changed from the prior year.
  • Preferred Stock Liabilities reached $21.1 million in Q2 2021 per IMRX's latest filing, down from $58.1 million in the prior quarter.
  • Across five years, Preferred Stock Liabilities topped out at $58.1 million in Q1 2021 and bottomed at $21.1 million in Q2 2020.